Rufinamide Tablet, Film Coated
Product Images NDC 59651-616

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Rufinamide (NDC 59651-616). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (200 mg (120 Tablets Bottle))

Package Label-principal Display Panel (200 mg (120 Tablets Bottle))
This is a description for Rufinamide tablets. Each film-coated tablet contains 200 mg of Rufinamide, a medication used for a specific purpose. The tablets are distributed by Aurobindo Pharma USA, Inc. The tablets are made in India and are stored between 20° and 25°C (68° to 77°F), with excursions permitted to 15° to 30°C (59° to 86°F). The medication guide is provided separately to each patient. The cap should be replaced securely after opening. This medication is available in a pack of 120 tablets. For more information, refer to the prescribing information and contact Aurobindo Pharma USA, Inc. at their address: 279 Princeton-Hightstown Road, East Windsor, NJ 08520.*
FDA Label Image

Package Label-principal Display Panel (400 mg (120 Tablets Bottle))

Package Label-principal Display Panel (400 mg (120 Tablets Bottle))
The text appears to be a description of a medication called Rufinamide Tablets, USP. The medication is meant to be dispensed with a separate Medication Guide for each patient. Each film-coated tablet contains 400 mg of Rufinamide. The dosage and use information can be found in the accompanying prescribing information. The tablets should be stored at a temperature of 20° to 25°C (68° to 77°F), with excursions permitted to 15° to 30°C (59° to 86°F). The tablets should be protected from moisture and the cap should be replaced securely after opening. The medication is distributed by Aurobindo Pharma USA, Inc. and was made in India. Unfortunately, the rest of the text is not readable.*
FDA Label Image

Str (Rufinamide Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.